You are here

Takeda

Actos Bladder Cancer Lawsuit 2015 Update

Legal Examiner

Sat, 01/10/15 - 12:48 pm

Takeda Names Sanofi’s Andrew Plump as Head of Research

Bloomberg

Thu, 12/18/14 - 08:59 am

Takeda targets gastrointestinal disease with its latest R&D deal

Fierce Biotech

Thu, 12/11/14 - 11:52 am

irritable bowel syndrome

Assessing The Beginnings Of The Orexigen Launch Of Contrave

Seeking Alpha

Wed, 12/10/14 - 05:47 pm

Six years and $8.8B later, Takeda is ditching the Millennium name

Fierce Biotech

Mon, 12/8/14 - 12:01 pm

Millennium Pharmaceuticals

Takeda Announces Formalization of Takeda Oncology to Enhance Discovery, Development and Global Commercialization of Breakthrough Cancer Medicines

Pipeline Review

Sun, 12/7/14 - 10:01 am

Seattle Genetics and Takeda Report Phase 3 AETHERA Clinical Trial Data from ADCETRIS® (Brentuximab Vedotin) in Post-Transplant Hodgkin Lymphoma Patients at Risk of Relapse at ASH Annual Meeting

Yahoo/BusinessWire

Sat, 12/6/14 - 11:15 am

Seattle Genetics

Hodgkin's lymphoma

Takeda Pharmaceuticals president quits

Chicago Business

Fri, 11/21/14 - 03:03 pm

Sanofi Said to Consider Smith & Nephew, Takeda for CEO

Bloomberg

Wed, 11/19/14 - 10:11 am

Takeda Ordered to Pay $155,000 for Destroying Actos Files

Bloomberg

Tue, 11/18/14 - 10:01 am

Takeda's Millennium re-ups with Presage on cancer drug combo effort

Fierce Biotech

Wed, 11/12/14 - 11:46 am

Millennium Pharmaceuticals

Presage Biosciences

Takeda recruits GE to help discover new liver treatments

Fierce Biotech

Tue, 11/11/14 - 01:20 pm

U.S. judge pares $9 bln award against Takeda, Eli Lilly over drug

Yahoo/Reuters

Mon, 10/27/14 - 05:26 pm

Takeda and Sucampo Enter Into Global Licensing Agreement for AMITIZA(R) (lubiprostone)

Yahoo

Thu, 10/23/14 - 08:36 am

Takeda and Orexigen Announce Availability of CONTRAVE® (naltrexone HCI and bupropion HCI) Extended-Release Tablets

Yahoo

Mon, 10/20/14 - 09:10 am

Latest Actos Bladder Cancer Trial Starts in West Virginia

Legal Examiner

Sun, 10/19/14 - 10:26 am

Orexigen pockets $100M in milestone cash for Contrave

Fierce Biotech

Wed, 10/15/14 - 12:26 pm

Millennium drug Velcade approved for wider use in the US

Boston Globe, MA

Fri, 10/10/14 - 09:53 am

Millennium Pharmaceuticals

non-Hodgkin's lymphoma

Salix: The Field of Potential Buyers is Vast, Analyst Says

WSJ Online

Tue, 10/7/14 - 04:52 pm

Takeda Accused of Putting Actos Profit Ahead of Safety

Bloomberg

Thu, 10/2/14 - 08:01 pm

Pages